CA2311119A1 - Method for transporting a molecular substance in predetermined areas of eucaryotic cells - Google Patents
Method for transporting a molecular substance in predetermined areas of eucaryotic cells Download PDFInfo
- Publication number
- CA2311119A1 CA2311119A1 CA002311119A CA2311119A CA2311119A1 CA 2311119 A1 CA2311119 A1 CA 2311119A1 CA 002311119 A CA002311119 A CA 002311119A CA 2311119 A CA2311119 A CA 2311119A CA 2311119 A1 CA2311119 A1 CA 2311119A1
- Authority
- CA
- Canada
- Prior art keywords
- molecular substance
- vehicle according
- protein
- pentamer
- viral protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
- C12N2710/22022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19829005.5 | 1998-06-29 | ||
DE19829005A DE19829005C2 (de) | 1998-06-29 | 1998-06-29 | Verfahren zum Transport molekularer Substanz in vorgegebene Bereiche eukaryontischer Zellen |
PCT/DE1999/001805 WO2000000224A2 (de) | 1998-06-29 | 1999-06-19 | Verfahren zum transport molekularer substanz in vorgegebene bereiche eukaryontischer zellen |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2311119A1 true CA2311119A1 (en) | 2000-01-06 |
Family
ID=7872407
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002311119A Abandoned CA2311119A1 (en) | 1998-06-29 | 1999-06-19 | Method for transporting a molecular substance in predetermined areas of eucaryotic cells |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1007107A2 (de) |
CA (1) | CA2311119A1 (de) |
DE (1) | DE19829005C2 (de) |
WO (1) | WO2000000224A2 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19952957B4 (de) * | 1999-11-03 | 2006-08-31 | Acgt Progenomics Ag | Modulare Transportsysteme für molekulare Substanzen und deren Herstellung und Verwendung |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1319101C (en) * | 1986-09-03 | 1993-06-15 | Marta Iris Sabara | Rotavirus nucleocapsid protein with or without binding peptides as immunologic carriers for macromolecules |
US4950599A (en) * | 1987-01-29 | 1990-08-21 | Wolf Bertling | Method for exchanging homologous DNA sequences in a cell using polyoma encapsulated DNA fragments |
CA2101735A1 (en) * | 1991-02-04 | 1992-08-05 | Mark J. Redmond | Vp6 encapsulated drug delivery |
DE4335025A1 (de) * | 1993-10-14 | 1995-04-20 | Boehringer Ingelheim Int | Endosomolytisch wirksame Partikel |
AU705035B2 (en) * | 1995-06-07 | 1999-05-13 | Baylor College Of Medicine | Nucleic acid transporters for delivery of nucleic acids into a cell |
GB9607899D0 (en) * | 1996-04-17 | 1996-06-19 | Scottish Crop Research Inst | Virus-like particle |
DE19618797C2 (de) * | 1996-05-10 | 2000-03-23 | Bertling Wolf | Vehikel zum Transport molekularer Substanz |
DE19750354A1 (de) * | 1997-11-13 | 1999-05-27 | November Ag Molekulare Medizin | Verfahren zur Applikation von Wirkstoffen |
-
1998
- 1998-06-29 DE DE19829005A patent/DE19829005C2/de not_active Expired - Fee Related
-
1999
- 1999-06-19 CA CA002311119A patent/CA2311119A1/en not_active Abandoned
- 1999-06-19 EP EP99939916A patent/EP1007107A2/de not_active Withdrawn
- 1999-06-19 WO PCT/DE1999/001805 patent/WO2000000224A2/de not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1007107A2 (de) | 2000-06-14 |
DE19829005A1 (de) | 1999-12-30 |
WO2000000224A2 (de) | 2000-01-06 |
DE19829005C2 (de) | 2000-08-31 |
WO2000000224A3 (de) | 2000-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1700911B1 (de) | Methode zur in vitro Auseinander- und Wiederzusammensetzung von Papillomavirus virus-ähnlichen Teilchen (VLPs) | |
KR0178022B1 (ko) | 단백질-다가양이온 결합체 | |
Georgens et al. | Recombinant virus like particles as drug delivery system | |
CA2856436A1 (en) | Uses of myostatin antagonists | |
CA2224907A1 (en) | Methods and means for targeted gene delivery | |
JP2006257088A (ja) | ポリヌクレオチド送達のための組成物および方法 | |
US7279306B2 (en) | Stable (fixed) forms of viral capsid proteins, and viral capsid protein fusions, preferably papillomavirus L1 proteins, and uses thereof | |
US7351533B2 (en) | In vitro method for disassmbly/reassembly of papillomavirus virus-like particles (VLPs). Homogeneous VLP and cavsomere compositions produced by said methods: use thereof as vehicle for improved purification, and delivery of active agents | |
SUN et al. | Sequences required for the nuclear targeting and accumulation of human papillomavirus type 6B L2 protein | |
US6380364B1 (en) | Chimeric biotin-binding papillomavirus protein | |
JP2003061693A (ja) | ウイルス様粒子、その製造方法およびその使用 | |
Günther et al. | Protein and peptide delivery via engineered polyomavirus‐like particles | |
JP2000500020A (ja) | 正十二面体様アデノウイルス・タンパク質複合体、それを含む組成物、及びその使用方法 | |
CA2311119A1 (en) | Method for transporting a molecular substance in predetermined areas of eucaryotic cells | |
US20230159596A1 (en) | Virus-like nanoparticles for oral delivery | |
JP3733329B2 (ja) | 分子性物質のためのモジュール式輸送系ならびにその製造方法および使用方法 | |
JPS61500971A (ja) | B型肝炎ウイルスの表面抗原と重合ヒト血清アルブミンレセプタ−とを有する粒子を含むワクチン製造に有用な組成物、前記の如き粒子を産生し得る動物細胞、並びにこれら細胞を得るための方法 | |
EP1250593B1 (de) | In-vitro-methode zur zerlegung und zum wiederzusammenfügen von papillomavirusartigen partikeln | |
US6962777B1 (en) | In vitro method for disassembly/reassembly of papillomavirus virus-like particles (vlps), homogeneous vlp and capsomere compositions produced by said methods; use thereof as vehicle for improved purification, and delivery of active agents | |
JP2002500637A (ja) | 遺伝物質のデリバリー用パポバウイルスカプシド蛋白質の使用 | |
EP0969013B1 (de) | Peptide zur Inhibition von HPV E7 Proteinen | |
Žáčková Suchanová | Targeting of viral nanoparticles to cancer specific receptors | |
Mäkelä et al. | Peptide-mediated interference with baculovirus transduction | |
US20030096259A1 (en) | In vitro method for disassembly/reassembly of papillomavirus virus-like particles (VLPs), homogeneous VLP and capsomere compositions produced by said methods; use thereof as vehicle for improved purification, and delivery of active agents | |
JP2003513628A (ja) | タンパク質シェルにおける分子性物質の定方向パッケージング方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |